320 related articles for article (PubMed ID: 15746922)
1. Activists angry at fallout from AIDS drug trial allegations.
Check E
Nat Med; 2005 Mar; 11(3):238. PubMed ID: 15746922
[No Abstract] [Full Text] [Related]
2. Activists and researchers rally behind AIDS drug for mothers.
Check E
Nature; 2004 Dec; 432(7020):935. PubMed ID: 15616517
[No Abstract] [Full Text] [Related]
3. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
4. Uganda gives lessons in stemming the AIDS epidemic.
Nat Med; 1999 Sep; 5(9):963. PubMed ID: 10470050
[No Abstract] [Full Text] [Related]
5. AIDS drug trials in Thailand and Uganda.
Simonds RJ
Nat Med; 1999 Nov; 5(11):1217. PubMed ID: 10545961
[No Abstract] [Full Text] [Related]
6. Establishment of drug-resistant HIV-1 in latent reservoirs.
Dahl V; Palmer S
J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
[No Abstract] [Full Text] [Related]
7. Inexpensive AIDS drug still reduces HIV transmission from mother to child after 1 year.
AIDS Read; 2000 Sep; 10(9):522. PubMed ID: 11019439
[No Abstract] [Full Text] [Related]
8. AIDS in Africa among women and infants: a human rights framework.
Gostin LO
Hastings Cent Rep; 2002; 32(5):9-10. PubMed ID: 12360777
[No Abstract] [Full Text] [Related]
9. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk].
MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137
[No Abstract] [Full Text] [Related]
10. Historical essay. Prospects for the future.
Gallo RC; Montagnier L
Science; 2002 Nov; 298(5599):1730-1. PubMed ID: 12459577
[No Abstract] [Full Text] [Related]
11. [Acquired immunodeficiency syndrome].
Rev Chilena Infectol; 2010 Aug; 27(4):359-73. PubMed ID: 21046725
[No Abstract] [Full Text] [Related]
12. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Ann N Y Acad Sci; 2000 Nov; 918():53-6. PubMed ID: 11131734
[No Abstract] [Full Text] [Related]
13. Reports on nevirapine threaten public health.
Lane HC; Folkers GK; Fauci AS
Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930
[No Abstract] [Full Text] [Related]
14. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
Kironde S; Lukwago J; Ssenyonga R
Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
[No Abstract] [Full Text] [Related]
15. The controversies of nevirapine for preventing mother-to-child HIV transmission.
Smith DM
AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
[No Abstract] [Full Text] [Related]
16. [Prevention of mother-to-child transmission with single dose nevirapine and human immunodeficiency virus drug resistance].
Han JF; Jiang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):730-3. PubMed ID: 19031772
[No Abstract] [Full Text] [Related]
17. South Africa in crisis on HIV/AIDS treatment.
Jones TT
Science; 2001 Jun; 292(5526):2431-2. PubMed ID: 11441877
[No Abstract] [Full Text] [Related]
18. Effect of maternal HIV-1 disease on infant outcome.
Sadovsky R
Am Fam Physician; 1997 Nov; 56(8):2088. PubMed ID: 9390100
[No Abstract] [Full Text] [Related]
19. [The UN Millennium Project; especially the prevention and treatment of the HIV-virus and AIDS in order to reduce child and maternal mortality].
van Dillen J; Stekelenburg J; van Roosmalen J
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1413-7. PubMed ID: 16841592
[TBL] [Abstract][Full Text] [Related]
20. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
Mellors JW; Chow JY
Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
